Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.
18-Sep-2020 8:30 AM EDT Add to Favorites
Cancer Research Institute Goes Virtual for Its Immunotherapy Patient Summit Series, Connecting Patients and Caregivers with Leading Experts in Cancer Immunotherapy
Free virtual event October 2-3 connecting cancer patients and caregivers with leading immunotherapy experts and patient advocates treated with immunotherapy
17-Sep-2020 4:45 PM EDT Add to Favorites
Cancer Research Institute Announces Recipients of 2020 Philanthropy and Science Awards to Be Presented at Virtual Gala, Innovators in Science and Philanthropy
Honorees recognized for supporting and making significant scientific advancements in cancer immunotherapy research to help create better treatment options for cancer patients
10-Sep-2020 7:00 AM EDT Add to Favorites
Cancer Research Institute Awards $30.2 Million in Grants and Fellowships to Support Basic and Clinical Research in Immunology and Cancer Immunotherapy
The Cancer Research Institute (CRI), a U.S. nonprofit organization dedicated to the discovery and development of powerful immunotherapies for all cancers, awarded more than $30.2 million in research grants and fellowships in the 2020 fiscal year...
5-Aug-2020 2:00 PM EDT Add to Favorites
Cancer Research Institute and The Mark Foundation for Cancer Research Launch Collaboration to Evaluate Liquid Biopsy for More Accurate and Rapid Assessment of Lung Cancer Patient Response to Immunotherapy
The Cancer Research Institute (CRI) and The Mark Foundation for Cancer Research have launched a clinical trial that aims to demonstrate the utility of a novel, ultra-sensitive biomarker-directed blood test, or liquid biopsy, in assessing cancer...
29-Jul-2020 8:55 AM EDT Add to Favorites
Eighth Annual Cancer Immunotherapy Month™ in June Celebrates Progress in Treatment and Advances in Research
June is Cancer Immunotherapy Month, a 30-day awareness campaign started by the Cancer Research Institute eight years ago to educate, inform, and inspire the global community of patients, caregivers, scientists, donors, and other cancer-concerned...
1-Jun-2020 11:40 AM EDT Add to Favorites
Rapid Growth in Global Development of Cancer Cellular Immunotherapies Highlighted by Latest Report from Cancer Research Institute and GlobalData
A new report, published in Nature Reviews Drug Discovery, reveals that the cellular immunotherapy landscape continues to expand, with 472 more cellular therapies in development now than one year ago
26-May-2020 9:00 AM EDT Add to Favorites
Cancer Research Institute and IQVIA Uncover the Impact of COVID-19 Pandemic on Global Oncology Clinical Trials
New study reveals impact of COVID-19 pandemic on cancer clinical trials, published in Nature Reviews Drug Discovery
18-May-2020 10:05 AM EDT Add to Favorites
See All News
The FDA announced on Aug 4 2009 that tumor necrosis factor (TNF) blockers used in the treatment of immune disorders carry an increased risk of lymphoma and other cancers in children and adolescents. The discoverer of TNF-alpha, Lloyd J. Old, M.D., a...
7-Aug-2009 9:00 AM EDT
Dendreon's PROVENGE for the treatment of advanced prostate cancer is the first active cellular immunotherapy to prolong patient survival, according to data from a pivotal phase III clinical trial announced at yesterday's AUA annual meeting in...
29-Apr-2009 11:20 AM EDT